The city of Durham, North Carolina, currently has 13 active clinical trials seeking participants for COVID19 research studies.
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
Recruiting
This study will seek to enroll immunocompromised patients with Lower Tract parainfluenza infection. It also contains a sub-study to enroll patients with severe COVID-19.
Gender:
All
Ages:
All
Trial Updated:
07/19/2023
Locations: Duke University, Durham, North Carolina
Conditions: Lower Respiratory Tract Infection, Parainfluenza, Immunocompromised, COVID-19